Clinical trial
Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects
NCT01665924 is registered in ClinicalTrials.gov with Lakefront Biotherapeutics NV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects
- Lead sponsor
- Lakefront Biotherapeutics NV
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- October 31, 2012
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy